Daniel Jacoby

11.0k citations
141 papers · 4.6k indexed · 5 hit papers · h-index 38

Impact in

    • Cardiomyopathy and Myosin Studies
    • Cardiovascular Function and Risk Factors
    • Cardiovascular Effects of Exercise
    • Heart Failure Treatment and Management
    • Viral Infections and Immunology Research
  • Nephrology top 2%

Papers in

    • Cardiomyopathy and Myosin Studies 51
    • Cardiovascular Function and Risk Factors 31
    • Cardiovascular Effects of Exercise 20
    • Heart Failure Treatment and Management 16
    • Viral Infections and Immunology Research 12
    • Cardiac pacing and defibrillation studies 11

Daniel Jacoby

134 papers receiving 4.5k citations

Hit Papers

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial 2021 · 127 citations
1272018202620202023100200300400

Peers

Daniel Jacoby
Comparison fields: 5 of 145
  • Cardiology and Cardiovascular Medicine 3.1k
  • Nephrology 259
  • Developmental Neuroscience 138
  • Health Informatics 29
  • Endocrinology, Diabetes and Metabolism 326
Replace Raphael Twerenbold with:
Raphael Twerenbold Switzerland
Stefan Störk Germany
Rustam Al‐Shahi Salman United Kingdom
Javier Sanz United States
Ray E. Hershberger United States
Frederick H. Epstein United States
Albert C. van Rossum Netherlands
Yasuhiko Sakata Japan
Marcus Hacker Austria
Andrew J. Taylor Australia
Daniel Jacoby relative to Raphael Twerenbold Switzerland Raphael Twerenbold's profile →
Citations per field
00.5×8.6×
Raphael Twerenbold · 1×
Citations per year

Countries citing papers authored by Daniel Jacoby

Since Specialization
Citations

This map shows the geographic impact of Daniel Jacoby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Jacoby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Jacoby more than expected).

Fields of papers citing papers by Daniel Jacoby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Jacoby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Jacoby. The network helps show where Daniel Jacoby may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Jacoby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Jacoby Line = papers co-authored together Daniel Jacoby links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy
Hit paper breakdown →
2018456
2
Empagliflozin in Heart Failure
Hit paper breakdown →
2020270
3
Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy
Hit paper breakdown →
2020246
4
Machine Learning Prediction of Mortality and Hospitalization in Heart Failure With Preserved Ejection Fraction
Hit paper breakdown →
2019208
5 2019196
6 2019180
7 2020128
8
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
Hit paper breakdown →
2021127
9 2016120
10 2011113
11 2021102
12 201699
13 201997
14 201691
15 200682
16 201782
17 201579
18 202178
19 201671
20 202070

About Daniel Jacoby

Daniel Jacoby is a scholar working on Cardiology and Cardiovascular Medicine, Transplantation, Developmental Neuroscience, Nephrology and Family Practice, having authored 141 papers that have together received 4.6k indexed citations. Recurring topics across this work include Cardiomyopathy and Myosin Studies (51 papers), Cardiovascular Function and Risk Factors (31 papers), Cardiac Structural Anomalies and Repair (20 papers), Cardiovascular Effects of Exercise (20 papers), Heart Failure Treatment and Management (16 papers), Viral Infections and Immunology Research (12 papers), Cardiac pacing and defibrillation studies (11 papers) and Mechanical Circulatory Support Devices (11 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (3.1k citations), Nephrology (259 citations), Developmental Neuroscience (138 citations), Health Informatics (29 citations) and Endocrinology, Diabetes and Metabolism (326 citations). Daniel Jacoby has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include William J. McKenna, Iacopo Olivotto, Carolyn Y. Ho, Lavanya Bellumkonda, Euan A. Ashley, Sharlene M. Day, Neal K. Lakdawala, Steven D. Colan, Adam Helms and Amy J. Sehnert. Their work appears in journals such as Circulation, Journal of Cardiac Failure, Journal of the American College of Cardiology, The Journal of Heart and Lung Transplantation and Circulation Heart Failure.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026